ADCTVSGTBP• 6 Months (Normalized)
ADCT vs GTBP (ADC Therapeutics SA vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 2 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ADCT Performance $1.23
-67.46%
ADC Therapeutics SA
Normalized Baseline0.00%
GTBP Performance $6.88
+1427.78%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1495.24 pts
GTBP outperforming by 1495.24 percentage points
ADCTGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ADCT GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | ADCT Price | ADCT Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.23 | -67.46% | $6.88 | +1427.78% | -1495.24% |
| Sep 28, 2026 | $1.26 | -66.67% | $6.80 | +1411.11% | -1477.78% |
| Sep 25, 2026 | $1.27 | -66.40% | $6.89 | +1431.11% | -1497.51% |
| Sep 24, 2026 | $1.29 | -65.87% | $6.83 | +1417.78% | -1483.65% |
| Sep 23, 2026 | $1.31 | -65.34% | $7.10 | +1477.78% | -1543.12% |
| Sep 22, 2026 | $1.23 | -67.46% | $- | - | |
| Sep 21, 2026 | $1.12 | -70.37% | $7.18 | +1495.56% | -1565.93% |
| Sep 18, 2026 | $1.05 | -72.22% | $7.16 | +1491.11% | -1563.33% |
| Sep 17, 2026 | $1.06 | -71.96% | $7.49 | +1564.44% | -1636.40% |
| Sep 16, 2026 | $1.05 | -72.22% | $7.81 | +1635.56% | -1707.78% |
| Sep 15, 2026 | $1.09 | -71.16% | $9.00 | +1900.00% | -1971.16% |
| Sep 14, 2026 | $1.11 | -70.63% | $11.63 | +2484.44% | -2555.07% |
| Sep 11, 2026 | $1.07 | -71.69% | $8.61 | +1813.33% | -1885.02% |
| Sep 10, 2026 | $1.11 | -70.63% | $6.18 | +1273.33% | -1343.96% |
| Sep 09, 2026 | $1.22 | -67.72% | $5.98 | +1228.89% | -1296.61% |
Page 1 of 9